Showing results (401-410 of 465) with videos related to
Sort By:
Pageof 47
Drug Safety|January 23, 2016
Social Media Listening for Routine Post-Marketing Safety SurveillanceGregory E Powell, Harry A Seifert, Tjark Reblin, et al.Neurosurgical Focus|October 4, 2016
Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experienceMir Amaan Ali, Kate T Carroll, Robert C Rennert, et al.Journal of Neuro-Oncology|August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapyJ Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.Journal of the American Academy of Dermatology|December 7, 2014
Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in MinnesotaJerry D Brewer, Tait D Shanafelt, Farzaneh Khezri, et al.Journal of Neuro-Oncology|January 10, 2022
Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experienceIsabela Peña Pino, Jun Ma, Yusuke S Hori, et al.Scientific Data|May 19, 2015
Global database of leishmaniasis occurrence locations, 1960-2012David M Pigott, Nick Golding, Jane P Messina, et al.World Neurosurgery|July 24, 2017
Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of LesionsMir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.Plos One|June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapyMasayuki Nitta, David Kozono, Richard Kennedy, et al.Journal of Neuro-Oncology|June 20, 2014
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort studyBrian J Scott, Vincent A van Vugt, Toni Rush, et al.Science Advances|December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survivalMichael A Harris, Huihui Kuang, Zachary Schneiderman, et al.Pageof 47